{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T11:26:29Z","timestamp":1787225189617,"version":"build-2736575974"},"reference-count":79,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001287","name":"The Elsa U Pardee Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001287","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000875","name":"The Pew Charitable Trusts","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000875","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Cell"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.molcel.2026.03.019","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T15:13:31Z","timestamp":1776352411000},"page":"1546-1559.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["mTORC1 activity suppresses ferroptosis through a SCARB1-dependent HDL-tocopherol uptake pathway"],"prefix":"10.1016","volume":"86","author":[{"given":"Thomas A.","family":"O\u2019Loughlin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S.","family":"Stiles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pritika","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abolfazl","family":"Arab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laine","family":"Goudy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashir A.","family":"Borah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uche N.","family":"Medoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke A.","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molcel.2026.03.019_bib1","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"mTOR Signaling in Growth, Metabolism, and Disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.molcel.2026.03.019_bib2","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s42255-019-0038-7","article-title":"Molecular logic of mTORC1 signalling as a metabolic rheostat","volume":"1","author":"Valvezan","year":"2019","journal-title":"Nat. Metab."},{"key":"10.1016\/j.molcel.2026.03.019_bib3","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrc839","article-title":"The phosphatidylinositol 3-Kinase AKT pathway in human cancer","volume":"2","author":"Vivanco","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.molcel.2026.03.019_bib4","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1146\/annurev.pathol.4.110807.092311","article-title":"PTEN and the PI3-kinase pathway in cancer","volume":"4","author":"Chalhoub","year":"2009","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.molcel.2026.03.019_bib5","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/s41568-018-0074-8","article-title":"mTOR signalling and cellular metabolism are mutual determinants in cancer","volume":"18","author":"Mossmann","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.molcel.2026.03.019_bib6","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nrd3531","article-title":"Rapamycin passes the torch: a new generation of mTOR inhibitors","volume":"10","author":"Benjamin","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.molcel.2026.03.019_bib7","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.cub.2004.06.054","article-title":"Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton","volume":"14","author":"Sarbassov","year":"2004","journal-title":"Curr. Biol."},{"key":"10.1016\/j.molcel.2026.03.019_bib8","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1126\/science.273.5272.239","article-title":"Structure of the FKBP12-rapamycin complex interacting with the binding domain of human FRAP","volume":"273","author":"Choi","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.molcel.2026.03.019_bib9","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1097-2765(02)00636-6","article-title":"Two TOR Complexes, Only One of which Is Rapamycin Sensitive, Have Distinct Roles in Cell Growth Control","volume":"10","author":"Loewith","year":"2002","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molcel.2026.03.019_bib10","doi-asserted-by":"crossref","first-page":"17414","DOI":"10.1073\/pnas.0809136105","article-title":"Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation","volume":"105","author":"Choo","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.molcel.2026.03.019_bib11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1042\/BJ20090489","article-title":"Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR)","volume":"421","author":"Garc\u00eda-Mart\u00ednez","year":"2009","journal-title":"Biochem. J."},{"key":"10.1016\/j.molcel.2026.03.019_bib12","doi-asserted-by":"crossref","first-page":"8023","DOI":"10.1074\/jbc.M900301200","article-title":"An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1","volume":"284","author":"Thoreen","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molcel.2026.03.019_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000038","article-title":"Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2","volume":"7","author":"Feldman","year":"2009","journal-title":"PLoS Biol."},{"key":"10.1016\/j.molcel.2026.03.019_bib14","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.cmet.2012.03.015","article-title":"Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c","volume":"15","author":"Hagiwara","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.molcel.2026.03.019_bib15","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1158\/2159-8290.CD-11-0085","article-title":"mTOR kinase inhibition causes feedback-dependent biphasic regulation of AKT signaling","volume":"1","author":"Rodrik-Outmezguine","year":"2011","journal-title":"Cancer Discov."},{"key":"10.1016\/j.molcel.2026.03.019_bib16","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ccr.2011.12.024","article-title":"Inhibition of PI3K\/mTOR leads to adaptive resistance in matrix-attached cancer cells","volume":"21","author":"Muranen","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.molcel.2026.03.019_bib17","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ccr.2010.10.031","article-title":"AKT inhibition relieves feedback suppression of receptor tyrosine kinase expression and activity","volume":"19","author":"Chandarlapaty","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.molcel.2026.03.019_bib18","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nature17963","article-title":"Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor","volume":"534","author":"Rodrik-Outmezguine","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.molcel.2026.03.019_bib19","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/s41589-021-00813-7","article-title":"Selective inhibitors of mTORC1 activate 4EBP1 and suppress tumor growth","volume":"17","author":"Lee","year":"2021","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.molcel.2026.03.019_bib20","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1021\/acs.jmedchem.2c01658","article-title":"Discovery of RMC-5552, a Selective Bi-Steric Inhibitor of mTORC1, for the Treatment of mTORC1-Activated Tumors","volume":"66","author":"Burnett","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.molcel.2026.03.019_bib21","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ccell.2017.01.014","article-title":"A Kinase Inhibitor Targeted to mTORC1 Drives Regression in Glioblastoma","volume":"31","author":"Fan","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.molcel.2026.03.019_bib22","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa063564","article-title":"Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis","volume":"358","author":"Bissler","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molcel.2026.03.019_bib23","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1371\/journal.pmed.0050008","article-title":"Antitumor activity of rapamycin in a Phase I trial for patients with recurrent PTEN-deficient glioblastoma","volume":"5","author":"Cloughesy","year":"2008","journal-title":"PLoS Med."},{"key":"10.1016\/j.molcel.2026.03.019_bib24","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1007\/s10637-018-0578-9","article-title":"A phase II study of the dual mTOR inhibitor MLN0128 in patients with metastatic castration resistant prostate cancer","volume":"36","author":"Graham","year":"2018","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.molcel.2026.03.019_bib25","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.eururo.2015.08.035","article-title":"A Randomised Phase 2 Study of AZD2014 Versus Everolimus in Patients with VEGF-Refractory Metastatic Clear Cell Renal Cancer","volume":"69","author":"Powles","year":"2016","journal-title":"Eur. Urol."},{"key":"10.1016\/j.molcel.2026.03.019_bib26","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0014-5793(99)00696-1","article-title":"Ratio-fluorescence microscopy of lipid oxidation in living cells using C11-BODIPY(581\/591)","volume":"453","author":"Pap","year":"1999","journal-title":"FEBS Lett."},{"key":"10.1016\/j.molcel.2026.03.019_bib27","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1006\/abio.1998.2931","article-title":"A Fluorometric Method for Measurement of Peroxyl Radical Scavenging Activities of Lipophilic Antioxidants","volume":"265","author":"Naguib","year":"1998","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.molcel.2026.03.019_bib28","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/ncb3341","article-title":"Glutathione biosynthesis is a metabolic vulnerability in PI(3)K\/Akt-driven breast cancer","volume":"18","author":"Lien","year":"2016","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.molcel.2026.03.019_bib29","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.cell.2011.06.034","article-title":"mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway","volume":"146","author":"Peterson","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.molcel.2026.03.019_bib30","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.28251","article-title":"Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells","volume":"63","author":"Sun","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.molcel.2026.03.019_bib31","doi-asserted-by":"crossref","first-page":"31189","DOI":"10.1073\/pnas.2017152117","article-title":"Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis","volume":"117","author":"Yi","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.molcel.2026.03.019_bib32","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.cell.2013.06.044","article-title":"CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes","volume":"154","author":"Gilbert","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.molcel.2026.03.019_bib78","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cell.2014.09.039","article-title":"A protein-tagging system for signal amplification in gene expression and fluorescence imaging","volume":"159","author":"Tanenbaum","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.molcel.2026.03.019_bib79","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.cell.2014.09.029","volume":"159","author":"Gilbert","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.molcel.2026.03.019_bib33","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1126\/science.271.5248.518","article-title":"Identification of Scavenger Receptor SR-BI as a High Density Lipoprotein Receptor","volume":"271","author":"Acton","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.molcel.2026.03.019_bib34","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0192-0561(97)00066-0","article-title":"Endotoxin contamination in fetal bovine serum and its influence on tumor necrosis factor production by macrophage-like cells J774.1 cultured in the presence of the serum","volume":"19","author":"Kirikae","year":"1997","journal-title":"Int. J. Immunopharmacol."},{"key":"10.1016\/j.molcel.2026.03.019_bib35","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1172\/JCI71610","article-title":"Lymphatic transport of high-density lipoproteins and chylomicrons","volume":"124","author":"Randolph","year":"2014","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.molcel.2026.03.019_bib36","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nature12684","article-title":"Structure of LIMP-2 provides functional insights with implications for SR-BI and CD36","volume":"504","author":"Neculai","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.molcel.2026.03.019_bib37","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1194\/jlr.R083121","article-title":"Scavenger receptor B type 1: expression, molecular regulation, and cholesterol transport function","volume":"59","author":"Shen","year":"2018","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.molcel.2026.03.019_bib38","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/10408360802118625","article-title":"Vitamin E in human health and disease","volume":"45","author":"Clarke","year":"2008","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.molcel.2026.03.019_bib39","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41580-023-00645-4","article-title":"Understanding mechanisms of antioxidant action in health and disease","volume":"25","author":"Halliwell","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.molcel.2026.03.019_bib40","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.tips.2017.02.005","article-title":"Ferroptosis Inhibition: Mechanisms and Opportunities","volume":"38","author":"Angeli","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.molcel.2026.03.019_bib41","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1016\/j.cell.2022.05.013","article-title":"Mapping information-rich genotype-phenotype landscapes with genome-scale Perturb-seq","volume":"185","author":"Replogle","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.molcel.2026.03.019_bib42","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.cmet.2008.07.007","article-title":"SREBP Activity Is Regulated by mTORC1 and Contributes to Akt-Dependent Cell Growth","volume":"8","author":"Porstmann","year":"2008","journal-title":"Cell Metab."},{"key":"10.1016\/j.molcel.2026.03.019_bib43","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.chembiol.2023.10.011","article-title":"Sensitization of cancer cells to ferroptosis coincident with cell cycle arrest","volume":"31","author":"Rodencal","year":"2024","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.molcel.2026.03.019_bib44","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s41586-021-03796-6","article-title":"Cycling cancer persister cells arise from lineages with distinct programs","volume":"596","author":"Oren","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.molcel.2026.03.019_bib45","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nature24297","article-title":"Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition","volume":"551","author":"Hangauer","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.molcel.2026.03.019_bib46","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nature23007","article-title":"Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway","volume":"547","author":"Viswanathan","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.molcel.2026.03.019_bib47","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.cell.2020.11.018","article-title":"Colorectal Cancer Cells Enter a Diapause-like DTP State to Survive Chemotherapy","volume":"184","author":"Rehman","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.molcel.2026.03.019_bib48","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nature20578","article-title":"Inhibition of mTOR induces a paused pluripotent state","volume":"540","author":"Bulut-Karslioglu","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.molcel.2026.03.019_bib49","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.chembiol.2022.10.006","article-title":"Ferroptosis inhibition by lysosome-dependent catabolism of extracellular protein","volume":"29","author":"Armenta","year":"2022","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.molcel.2026.03.019_bib50","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41589-021-00751-4","article-title":"A compendium of kinetic modulatory profiles identifies ferroptosis regulators","volume":"17","author":"Conlon","year":"2021","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.molcel.2026.03.019_bib51","article-title":"mTORC1 couples cyst(e)ine availability with GPX4 protein synthesis and ferroptosis regulation","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molcel.2026.03.019_bib52","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41586-025-09162-0","article-title":"Glycosaminoglycan-driven lipoprotein uptake protects tumours from ferroptosis","volume":"644","author":"Calhoon","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.molcel.2026.03.019_bib53","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S0022-2275(20)31605-9","article-title":"Characterization of four lipoprotein classes in human cerebrospinal fluid","volume":"42","author":"Koch","year":"2001","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.molcel.2026.03.019_bib54","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0022-2275(20)32039-3","article-title":"Characterization and functional studies of lipoproteins, lipid transfer proteins, and lecithin:cholesterol acyltransferase in CSF of normal individuals and patients with Alzheimer\u2019s disease","volume":"41","author":"Demeester","year":"2000","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.molcel.2026.03.019_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2025.100865","article-title":"Cerebrospinal fluid lipoprotein-mediated cholesterol delivery to neurons is impaired in Alzheimer\u2019s disease and involves APOE4","volume":"66","author":"Borr\u00e0s","year":"2025","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.molcel.2026.03.019_bib56","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","article-title":"FSP1 is a glutathione-independent ferroptosis suppressor","volume":"575","author":"Doll","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.molcel.2026.03.019_bib57","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","article-title":"The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis","volume":"575","author":"Bersuker","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.molcel.2026.03.019_bib58","article-title":"Bioavailability of Coenzyme Q10: An Overview of the Absorption Process and Subsequent Metabolism","volume":"9","author":"Mantle","year":"2020","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.molcel.2026.03.019_bib59","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/s41556-024-01425-8","article-title":"Exploiting ferroptosis vulnerabilities in cancer","volume":"26","author":"Nakamura","year":"2024","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.molcel.2026.03.019_bib61","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.44288","article-title":"The CUL5 ubiquitin ligase complex mediates resistance to CDK9 and MCL1 inhibitors in lung cancer cells","volume":"8","author":"Kabir","year":"2019","journal-title":"eLife"},{"key":"10.1016\/j.molcel.2026.03.019_bib60","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aaw9450","article-title":"KRASG12C inhibition produces a driver-limited state revealing collateral dependencies","volume":"12","author":"Lou","year":"2019","journal-title":"Sci. Signal."},{"key":"10.1016\/j.molcel.2026.03.019_bib62","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.81856","article-title":"Maximizing CRISPRi efficacy and accessibility with dual-sgRNA libraries and optimal effectors","volume":"11","author":"Replogle","year":"2022","journal-title":"eLife"},{"key":"10.1016\/j.molcel.2026.03.019_bib63","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.19760","article-title":"Compact and highly active next-generation libraries for CRISPR-mediated gene repression and activation","volume":"5","author":"Horlbeck","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.molcel.2026.03.019_bib64","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/nprot.2013.143","article-title":"Genome engineering using the CRISPR-Cas9 system","volume":"8","author":"Ran","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.molcel.2026.03.019_bib65","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/mt.2008.6","article-title":"A Multicolor Panel of Novel Lentiviral \u201cGene Ontology\u201d (LeGO) Vectors for Functional Gene Analysis","volume":"16","author":"Weber","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.molcel.2026.03.019_bib66","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nbt.3882","article-title":"Alternative drug sensitivity metrics improve preclinical cancer pharmacogenomics","volume":"35","author":"Hafner","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.molcel.2026.03.019_bib67","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nmeth.3853","article-title":"Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugs","volume":"13","author":"Hafner","year":"2016","journal-title":"Nat. Methods"},{"key":"10.1016\/j.molcel.2026.03.019_bib68","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-017-3689-3","article-title":"GRcalculator: an online tool for calculating and mining dose\u2013response data","volume":"17","author":"Clark","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.molcel.2026.03.019_bib69","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.gpb.2022.01.004","article-title":"SynergyFinder Plus: Toward Better Interpretation and Annotation of Drug Combination Screening Datasets","volume":"20","author":"Zheng","year":"2022","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"10.1016\/j.molcel.2026.03.019_bib70","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.csbj.2015.09.001","article-title":"Searching for Drug Synergy in Complex Dose-Response Landscapes Using an Interaction Potency Model","volume":"13","author":"Yadav","year":"2015","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.molcel.2026.03.019_bib77","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.molcel.2026.03.019_bib71","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1101\/gr.209601.116","article-title":"UMI-tools: modeling sequencing errors in Unique Molecular Identifiers to improve quantification accuracy","volume":"27","author":"Smith","year":"2017","journal-title":"Genome Res."},{"key":"10.1016\/j.molcel.2026.03.019_bib72","doi-asserted-by":"crossref","DOI":"10.14806\/ej.17.1.200","article-title":"Cutadapt removes adapter sequences from high-throughput sequencing reads","volume":"17","author":"Martin","year":"2011","journal-title":"EMBnet J."},{"key":"10.1016\/j.molcel.2026.03.019_bib73","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.molcel.2026.03.019_bib74","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","article-title":"HTSeq\u2014a Python framework to work with high-throughput sequencing data","volume":"31","author":"Anders","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.molcel.2026.03.019_bib75","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btad547","article-title":"PyDESeq2: a python package for bulk RNA-seq differential expression analysis","volume":"39","author":"Muzellec","year":"2023","journal-title":"Bioinformatics"},{"key":"10.1016\/j.molcel.2026.03.019_bib76","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1093\/bioinformatics\/btac076","article-title":"blitzGSEA: efficient computation of gene set enrichment analysis through gamma distribution approximation","volume":"38","author":"Lachmann","year":"2022","journal-title":"Bioinformatics"}],"container-title":["Molecular Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1097276526001954?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1097276526001954?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T15:14:47Z","timestamp":1776352487000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1097276526001954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":79,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1097276526001954"],"URL":"https:\/\/doi.org\/10.1016\/j.molcel.2026.03.019","relation":{},"ISSN":["1097-2765"],"issn-type":[{"value":"1097-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"mTORC1 activity suppresses ferroptosis through a SCARB1-dependent HDL-tocopherol uptake pathway","name":"articletitle","label":"Article Title"},{"value":"Molecular Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molcel.2026.03.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}